Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma

Abstract Objectives Glioblastoma is a highly aggressive and fatal brain malignancy, and effective targeted therapies are required. The combination of standard treatments including surgery, chemotherapy and radiotherapy is not curative. Chimeric antigen receptor (CAR) T cells are known to cross the b...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes‐Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Wiley 2023-01-01
Serie:	Clinical & Translational Immunology
Ämnen:	CAR T cells chimeric antigen receptor EGFRvIII glioblastoma immunotherapy
Länkar:	https://doi.org/10.1002/cti2.1440
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!